Accumulating evidence unveils that HNRNPA2B1 as a m6A reader harbors an increased expression in multiple malignances including NSCLC [11–18] and indicates poor prognosis in patients with NSCLC [17, 34]. This evidence concerns the gene HNRNPA2B1 and non-small cell lung carcinoma.